Cargando…

Hypertrophic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Butt, Asra K., Alkhatib, Deya, Pour-Ghaz, Issa, Isa, Sakiru, Al-Taweel, Omar, Ugonabo, Ifeoma, Yedlapati, Neeraja, Jefferies, John Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053221/ https://www.ncbi.nlm.nih.gov/pubmed/36975870 http://dx.doi.org/10.3390/jcdd10030106

Ejemplares similares

Novel Device Therapies for Heart Failure
por: Alkhatib, Deya, et al.
Publicado: (2023)

The Roles of Coronary Computed Tomography Angiography in Characterizing Coronary Plaque: Screening, Treatment, and Prevention
por: Pour-Ghaz, Issa, et al.
Publicado: (2023)

A Case of Low Ejection Fraction Unrelated to Anthracycline Therapy: Chemo Tells a Fib
por: DeCarr, Kimberly, et al.
Publicado: (2023)

A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis
por: Adeboye, Adedayo, et al.
Publicado: (2022)

Primary Cardiac Sarcoma: Angiosarcoma Compressing the Right Coronary Artery
por: Mubder, Mohamad, et al.
Publicado: (2023)

Barth Syndrome: Psychosocial Impact and Quality of Life Assessment
por: Bath, Anandbir, et al.
Publicado: (2022)

Arrhythmogenic Ventricular Cardiomyopathy: Challenges With Complex Genetics and Variable Phenotypes
por: Rawal, Aranyak S., et al.
Publicado: (2021)

Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy
por: Pour-Ghaz, Issa, et al.
Publicado: (2022)

Cardiac Amyloidosis: A Rare TTR Mutation Found in an Asian Female
por: Mouksian, Kristina, et al.
Publicado: (2023)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Left Ventricular Thrombus in Hypertrophic Cardiomyopathy
por: Hamada, Mareomi
Publicado: (2018)

Genetic and Molecular Mechanisms of Hypertrophic Cardiomyopathy
por: Chou, Chun, et al.
Publicado: (2023)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
por: Siontis, Konstantinos C., et al.
Publicado: (2019)

Hypertrophic Cardiomyopathy—Current Challenges and Future Perspectives
por: Monda, Emanuele, et al.
Publicado: (2023)

Levamisole-induced Vasculitis in a Hepatitis C Patient: A General Medicine Ward Perspective on Diagnosis and Management
por: Latif, Zara, et al.
Publicado: (2019)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy
por: Minami, Yuichiro, et al.
Publicado: (2018)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Role of the Extracellular Matrix in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Marian, Ali J.
Publicado: (2019)

Are We Getting Closer to Risk Stratification in Left Ventricular Noncompaction Cardiomyopathy?
por: Jefferies, John L.
Publicado: (2018)

The consolidation of surgery for hypertrophic obstructive cardiomyopathy in Asia and the Pacific Rim
por: Quintana, Eduard, et al.
Publicado: (2021)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Ventricular Arrhythmias in Hypertrophic Cardiomyopathy- Can We Ever Predict Them?
por: Namboodiri, Narayanan, et al.
Publicado: (2010)

Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence
por: McKeown, Pascal P, et al.
Publicado: (2013)

Will the Mitral Clip become the invasive treatment of choice for hypertrophic obstructive cardiomyopathy?
por: Alkhouli, Mohamad
Publicado: (2014)

Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy
por: Schindler, Thomas H., et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
por: Pandian, Natesa G, et al.
Publicado: (2015)

Longitudinal Changes of Left Atrial Volume Index as a Prognosticator in Hypertrophic Cardiomyopathy
por: Kim, Sungseek, et al.
Publicado: (2023)

Detection of apical hypertrophic cardiomyopathy; which is the appropriate imaging modality
por: van der Wall, E. E., et al.
Publicado: (2008)

Hypertrophic cardiomyopathy: Ischemia progressing to ventricular fibrillation
por: Rochelson, Ellis, et al.
Publicado: (2018)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Emergence of endocardium/epicardium flow gradient as novel risk biomarker in patients with hypertrophic cardiomyopathy
por: Schindler, Thomas H., et al.
Publicado: (2020)

Emerging Indicators of Left Atrial Function Evaluation Considering the Unique Characteristics of Hypertrophic Cardiomyopathy
por: Chung, Hyemoon
Publicado: (2023)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r5lseeo6muua47c8kmpl48pj30